concept

HIPPO

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HIPPO: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

643Connections
30Hypotheses
0Analyses
50Outgoing
50Incoming
15Experiments
0Debates

Summary

HIPPO is a concept in neurodegeneration research. Key relationships include: regulates, activates, therapeutic target. Associated with Aging, Als, Alzheimer. Connected to 425 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameHIPPO
Key Genes/ProteinsABCB1, ACSL4, Actin, AGING, AKT, ALS
Related DiseasesAddiction, Aging, Als, Alzheimer
Related PathwaysAkt, Amyloid

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Hippo Signaling Pathway in Neurodegeneration

mechanism · 1922 words

Pathway Diagram

graph TD
    HIPPO["HIPPO"]
    HIPPO -->|"interacts"| FoxO1["FoxO1"]
    HIPPO -->|"regulates"| TNF_["TNFalpha"]
    HIPPO -->|"regulates"| IL_6["IL-6"]
    HIPPO -->|"regulates"| Carcinoma["Carcinoma"]
    HIPPO -->|"regulates"| Als["Als"]
    HIPPO -->|"target for"| Ms["Ms"]
    HIPPO -->|"target for"| Inflammation["Inflammation"]
    HIPPO -->|"activates"| Cancer["Cancer"]
    HIPPO -->|"target for"| Tumor["Tumor"]
    CDH1["CDH1"] -->|"regulates"| HIPPO
    MPXV["MPXV"] -->|"regulates"| HIPPO
    MTOR["MTOR"] -->|"regulates"| HIPPO
    AGING["AGING"] -->|"inhibits"| HIPPO
    GAL["GAL"] -->|"regulates"| HIPPO
    FOS["FOS"] -->|"contributes to"| HIPPO
    MT_ATP6["MT-ATP6"] -->|"regulates"| HIPPO
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"regulates"| HIPPO
    PI3K["PI3K"] -->|"regulates"| HIPPO

Outgoing (414)

TargetRelationTypeStr
Cancerregulatesdisease1.00
Cancertherapeutic_targetdisease1.00
Tumortherapeutic_targetdisease1.00
Alstherapeutic_targetdisease1.00
Hippo Pathwayregulatespathway1.00

Incoming (229)

SourceRelationTypeStr
CANCERregulatesgene0.80
APOPTOSISregulatesgene0.80
TAZregulatesgene0.70
PI3Ktherapeutic_targetgene0.70
APOPTOSISactivatesgene0.70

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop transcranial focused ultrasound with 40Hz gamma 1.000 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.948 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.922 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.912 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic restoration of hippocampal gamma oscillations vi 0.863 Alzheimer's disease Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 0.861 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.858 Alzheimer's disease Circuit-level neural dynamics in neurode
Gamma entrainment therapy to restore hippocampal-cortical sy 0.851 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic viral vector delivery via tFUS-mediated blood-br 0.846 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic restoration of hippocampal gamma oscillations vi 0.845 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna 0.820 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.797 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial alternating current stimulation to 0.785 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.767 Alzheimer's disease Circuit-level neural dynamics in neurode
Cholinergic Basal Forebrain-Hippocampal Circuit Protection 0.742 neuroscience Circuit-level neural dynamics in neurode
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio 0.740 neuroscience Circuit-level neural dynamics in neurode
Hippocampal-Cortical Transcriptomic Divergence Reveals Accel 0.680 Alzheimer disease Allen Mouse Brain Aging Atlas: cross-age
Locus Coeruleus-Hippocampal Circuit Protection 0.653 neuroscience Circuit-level neural dynamics in neurode
TDP-43 Cryptic Exon–Targeted ASOs to Restore Hippocampal Gam 0.577 neurodegeneration RNA binding protein dysregulation across
LRP1-mediated synaptic uptake drives early entorhinal-hippoc 0.570 neurodegeneration Which tau propagation mechanism predomin
Closed-loop transcranial focused ultrasound to restore hippo 0.564 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting entorh 0.564 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.564 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic restoration of hippocampal gamma oscillations vi 0.555 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.551 Alzheimer's disease Circuit-level neural dynamics in neurode
Hippocampus ages transcriptionally faster than cerebellum, d 0.516 Alzheimer's disease Allen Mouse Brain Aging Atlas: cross-age
Age-dependent downregulation of KPNA2 creates limbic neuron- 0.452 neurodegeneration What mechanisms drive TDP-43 pathology s
HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks enhances hip 0.450 neurodegeneration What are the optimal oxygen pressure, du

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (15)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn clinical Alzheimer's disease and relate 0.950 0.00 human patients proposed N/A
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A
SIRPα modulation in mouse models of Alzheimer's disease validation Alzheimer's disease 0.900 0.00 mouse models of Alzheimer's di proposed N/A
Tet2 modulation in Aβ42-injured mouse hippocampal neurons exploratory Alzheimer's disease 0.900 0.00 primary mouse hippocampal neur proposed N/A
Synaptic plasticity and protein expression analysis in mPFC exploratory insomnia-anxiety comorbidity 0.850 0.00 mPFC brain slices from PCPA-tr proposed N/A
Microglial SIRPα expression in human Alzheimer's disease tissue exploratory Alzheimer's disease 0.800 0.00 human brain tissue proposed N/A
Brain Connectivity-Targeted tACS Trial in Early AD clinical Alzheimer's Disease 0.509 0.50 human postmortem brain tissue proposed $520,000
s:** - Test whether HCN1 knockout specifically in EC layer II accelera falsification Alzheimer's Disease 0.400 0.50 cell_line proposed $80,000
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Positive Indiv clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau clinical Alzheimer's Disease 0.400 0.50 cell_line proposed $180,000
Biomarker-Guided Sequential Therapy Selection in Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
tACS Connectivity Trial in Early Alzheimer's clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Brain Connectivity-Targeted tACS Trial in Early AD clinical Alzheimer's Disease 0.400 0.50 mouse proposed $730,000
Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecular Basis clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] Han QQ, Shen SY, Liang LF, Chen XR, Yu J Brain Behav Immun 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Anatomical and neurochemical profiles of somatostatin-positive neurons in the mo [PMID:41796787] Tomioka R, Kobayashi K, Song WJ Neuroscience 2026 0
Subtype-Specific Roles of Anterior Cingulate Cortex Neurons in Pain-Induced Soci [PMID:41799202] Wan X, Yan Z, Zhang Z, Liu X, Yang D, Zh Theranostics 2026 0
A comparative analysis of pig-to-rhesus corneal xenotransplantation with various [PMID:41928466] Lee SH, Yoon CH, Choi HJ, Lee HJ, Kang H Korean J Ophthalmol 2026 0
Epigenetically regulated pancreatic GABA-somatostatin signaling underlies gestat [PMID:41779871] Zhu H, Luo S, Liu C, Cheng Y, Ren Z, Mo Science translational medicine 2026 0
Therapeutic Potential of Somatostatin and Its Analogues in Alzheimer's Disease: [PMID:41854733] Liu K, Zhang XY, Wang YT, Wang R, Jin RH Molecular neurobiology 2026 0
Altered Expression of GABA-Related Genes in Schizophrenia: Insights from Meta-An [PMID:41788138] Singer Y, Yitzhaky A, Hertzberg L Alpha psychiatry 2026 0
Paracrine inhibition via G protein inwardly rectifying potassium channels regula [PMID:41824458] Panzer JK, Lang AL, Levi NJ, Garcia PA, Cell reports 2026 0
GADD45G operates as a pathological sensor orchestrating reactive gliosis and neu [PMID:40409253] Shen T, Tai W, Jiang D, Ma S, Zhong X, Z Neuron 2025 0
Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheime [PMID:41035073] Castanho I, Naderi Yeganeh P, Boix CA, M Molecular neurodegeneration 2025 0
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974] Dai L, Wang J, Meng L, Zhang X, Xiao T, PLoS biology 2025 0
Molecular hallmarks of excitatory and inhibitory neuronal resilience and resista [PMID:39868232] Castanho I, Yeganeh PN, Boix CA, Morgan bioRxiv : the preprint server 2025 0
From stress to Alzheimer's: A circuit-based framework for prefrontal cognitive d [PMID:41115499] Yi JH Neuroscience letters 2025 0
Hippocampal Interneurons Shape Spatial Coding Alterations in Neurological Disord [PMID:40392508] Ikebara JM, Jorge RS, Marinho LSR, Higa Molecular neurobiology 2025 0
Somatostatin and the pathophysiology of Alzheimer's disease. [PMID:38484981] Almeida VN Ageing Res Rev 2024 0
Somatostatin and the pathophysiology of Alzheimer's disease. [PMID:38484981] Almeida VN Ageing research reviews 2024 0
Sterols and pentacyclic triterpenoids from nettle root: content and composition [PMID:36478201] ["Cegledi E", "Repaji\u0107 M", "Balbino Journal of the science of food 2023 0
The association between the type of progesterone supplementation and miscarriage [PMID:37156908] ["Shaulov T", "Zanr\u00e9 N", "Phillips Archives of gynecology and obs 2023 0
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. [PMID:38102334] ["Lai X", "Lui S", "Lam H", "Adachi Y", NPJ precision oncology 2023 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning HIPPO in their description or question text

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stab

Score: 0.861 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization starts

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.858 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct

Gamma entrainment therapy to restore hippocampal-cortical synchrony

Score: 0.851 · Alzheimer's disease · 2026-04-02

## Mechanistic Overview Gamma entrainment therapy to restore hippocampal-cortical synchrony starts from the claim that m

Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening

Score: 0.846 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening to restore hippo

Optogenetic restoration of hippocampal gamma oscillations via selective SST inte

Score: 0.845 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective SST interneuron activati

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.827 · Alzheimer's disease · 2026-04-16

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST inter

Score: 0.827 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to resto

Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation

Score: 0.820 · Alzheimer's disease · 2026-04-02

## Mechanistic Overview Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation starts from the cl

Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with r

Score: 0.797 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma f

Closed-loop transcranial alternating current stimulation to restore hippocampal-

Score: 0.785 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop transcranial alternating current stimulation to restore hippocampal-prefrontal gamma

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.767 · Alzheimer's disease · 2026-04-12

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via somato

Cholinergic Basal Forebrain-Hippocampal Circuit Protection

Score: 0.742 · neuroscience · 2026-04-07

## **Molecular Mechanism and Rationale** The cholinergic basal forebrain-hippocampal circuit protection hypothesis cent

Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection

Score: 0.740 · neuroscience · 2026-04-07

## Mechanistic Overview Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection starts from the claim that modulat

Hippocampal-Cortical Transcriptomic Divergence Reveals Accelerated Neurodegenera

Score: 0.680 · Alzheimer disease · 2026-04-24

## Mechanistic Overview Hippocampal-Cortical Transcriptomic Divergence Reveals Accelerated Neurodegeneration-Like Signat

Locus Coeruleus-Hippocampal Circuit Protection

Score: 0.653 · neuroscience · 2026-04-04

## Mechanistic Overview Locus Coeruleus-Hippocampal Circuit Protection starts from the claim that modulating MAPT within